Estrogen binding sites in hamster white adipose tissue: sex- and site-related variations; modulation by testosterone.
Estrogen binding sites (ER) were studied, using 17 beta-[3H]estradiol as the ligand, in epididymal or parametrial and subcutaneous adipose tissues of male and female hamsters. Compared with other mammalian fat deposits, intact male and female hamsters possess abundant estrogen binding sites with moderate affinity for estradiol and which occur as a single class of receptor in males but as two populations in females. The levels of estrogen receptors depend on both sex and tissue localization. In males, receptor densities are higher in both localizations when compared to those of females and ER are more abundant in superficial adipose deposits than in the deep fat tissue. In females, there are two estrogen binding populations; the one with the highest affinity is similar to the classical estrogen receptor and both populations are more abundant in deep fat than in subcutaneous deposits, in contrast to male hamsters. These characteristics depend on androgen status: in male adipose tissues, testosterone (TP) up-regulates the ER levels. Conversely, in female fat deposits, TP down-regulates the highest affinity estrogen receptors and the lowest affinity population disappears. Binding affinities are never affected by testosterone. These results suggest that, in hamster adipose tissue, estrogen receptors exhibit site- and sex-related differences, as previously described for androgen receptors. Furthermore, estrogen receptor expression is modulated by the androgen status, depending on gender, which could be related to some physiological situations observed in the hamster.
Jaubert
A M
AM
Department of Biochemistry, INSERM CJF 94-02, Faculty of Medicine Paris-Ouest, Université Paris V, Poissy, France.
Pecquery
R
R
Dieudonne
M N
MN
Giudicelli
Y
Y
D000273:Adipose Tissue / Q000187:drug effects / Q000378:metabolism*; D000818:Animals; D001665:Binding Sites; D001667:Binding, Competitive / Q000187:drug effects; D002352:Carrier Proteins / Q000378:metabolism; D006224:Cricetinae; D003600:Cytosol / Q000187:drug effects / Q000378:metabolism; D005260:Female; D007118:Immunoassay; D007202:Indicators and Reagents; D007700:Kinetics; D008297:Male; D008647:Mesocricetus; D009928:Organ Specificity; D011960:Receptors, Estrogen / Q000187:drug effects / Q000378:metabolism*; D012727:Sex Characteristics; D013739:Testosterone / Q000494:pharmacology*; D015854:Up-Regulation / Q000187:drug effects
D002352:Carrier Proteins; D007202:Indicators and Reagents; D011960:Receptors, Estrogen; C010140:estrophilin; D013739:Testosterone